Hematology TimesAdult CCSs report financial hardshipsAugust 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsIsavuconazole resolved invasive fungal disease in patients on ibrutinibJuly 29, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersCLL
Hematology TimesGlobal burden of hematologic malignanciesJuly 29, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology TimesDrug receives fast track designation for WMJuly 26, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesFDA approves biosimilar filgrastimJuly 22, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Hematology TimesDiabetics have higher risk of hematologic, other cancersJuly 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology TimesPET-guided treatment didn’t improve outcomesJuly 16, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsNew guideline for managing MCLJuly 13, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsIbrutinib/venetoclax shows early promise in relapsed CLLJuly 11, 2018CLLAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology TimesHealth Canada expands approval of obinutuzumabJuly 10, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesTransplant strategy not viable for aggressive B-NHLJuly 6, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology NewsRapid venetoclax dose escalation aids relapsed CLLJuly 5, 2018Aggressive LymphomasCLLLymphoma & Plasma Cell Disorders
Hematology TimesJAK inhibition linked to B-cell lymphomaJuly 5, 2018CythemiasLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology TimesCHMP recommends CAR T for ALL, DLBCLJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesCHMP recommends CAR T for DLBCL, PMBCLJuly 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
